Brokerages expect Invuity, Inc. (NASDAQ:IVTY) to report ($0.55) earnings per share for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Invuity’s earnings, with the highest EPS estimate coming in at ($0.48) and the lowest estimate coming in at ($0.60). Invuity posted earnings per share of ($0.56) in the same quarter last year, which indicates a positive year-over-year growth rate of 1.8%. The company is expected to issue its next earnings report after the market closes on Tuesday, November 7th.

On average, analysts expect that Invuity will report full year earnings of ($2.39) per share for the current fiscal year, with EPS estimates ranging from ($2.51) to ($2.29). For the next fiscal year, analysts forecast that the business will post earnings of ($1.76) per share, with EPS estimates ranging from ($2.01) to ($1.62). Zacks’ earnings per share calculations are a mean average based on a survey of analysts that cover Invuity.

IVTY has been the subject of a number of research reports. Piper Jaffray Companies restated a “buy” rating and set a $10.00 target price on shares of Invuity in a research report on Wednesday, July 26th. Northland Securities restated a “buy” rating and set a $13.00 target price on shares of Invuity in a research report on Tuesday, September 26th. Zacks Investment Research upgraded shares of Invuity from a “sell” rating to a “hold” rating in a research report on Wednesday, October 4th. Finally, ValuEngine upgraded shares of Invuity from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. One research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $11.00.

TRADEMARK VIOLATION NOTICE: This news story was posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/11/05/invuity-inc-ivty-expected-to-announce-earnings-of-0-55-per-share.html.

Shares of Invuity (NASDAQ IVTY) opened at $8.90 on Friday. The company has a current ratio of 3.07, a quick ratio of 2.63 and a debt-to-equity ratio of 1.51. Invuity has a 1-year low of $4.50 and a 1-year high of $9.70.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. CAPROCK Group Inc. lifted its position in Invuity by 28.6% during the third quarter. CAPROCK Group Inc. now owns 45,000 shares of the medical instruments supplier’s stock valued at $401,000 after purchasing an additional 10,000 shares during the period. OxFORD Asset Management LLP acquired a new position in Invuity during the second quarter valued at $374,000. B. Riley Financial Inc. acquired a new position in shares of Invuity in the second quarter worth about $3,625,000. Royce & Associates LP raised its position in shares of Invuity by 141.9% in the second quarter. Royce & Associates LP now owns 98,939 shares of the medical instruments supplier’s stock worth $717,000 after acquiring an additional 58,033 shares during the period. Finally, FMR LLC raised its position in shares of Invuity by 0.5% in the first quarter. FMR LLC now owns 829,564 shares of the medical instruments supplier’s stock worth $6,595,000 after acquiring an additional 4,264 shares during the period. Institutional investors own 66.02% of the company’s stock.

About Invuity

Invuity, Inc, a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges.

Get a free copy of the Zacks research report on Invuity (IVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Invuity (NASDAQ:IVTY)

Receive News & Ratings for Invuity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invuity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.